Interestingly, heat stroke incidents are more frequent among the elderly.
The Swedish Stroke Register (Riks-Stroke)* includes all acute stroke incidents in hospitals since 1998 (with some limited data from 1994 onwards).
The paradox of cholesterol and stroke is also seen in the effect of statins on stroke incidence; the greater the reduction of LDL with statin treatment, the lower the risk of stroke despite the absence of association of baseline LDL and stroke incidents [ 149].
These effects are considerable and present more than 10 years before the stroke incident.
Routine hospital discharge diagnoses have limitations as a sole basis for estimating stroke incident rates.
Consequently, the time between the stroke incident and the in-depth interviews ranged from seven to ten months.
Every year, 25,000 to 26,000 unique health care cases of stroke are reported in the registry, including the acute phase of stroke, and follow up at 3 and 12 months post stroke incident for each patient [ 15].
However, no studies have evaluated the health and social burden before the stroke on patients and their partners in terms of the total socioeconomic costs before and after the stroke incident.
All 72 hospitals providing acute stroke care partake in the registry, reporting altogether 25,000 to 26,000 unique healthcare cases of stroke each year, including the acute phase of stroke, and follow-up at 3 and 12 months following the stroke incident for each patient [ 20].
Patients receiving a supplement had a 46%% reduced risk of total cardiovascular events, including acute MI, ischaemic stroke, incident peripheral vascular disease, and unstable angina (RR 0.54, 95%% CI 0.33 0.89), and a 55%% reduced risk of MI RRR 0.45, 95%% CI 0.20 0.99).
Secondary prospective outcomes were incident stroke and incident CHD defined as myocardial infarction (MI), fatal CHD, silent MI from EKG, or cardiac revascularization procedure[37], [38].
